Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Parkinson Disease News

News
PD-Related Genes Contribute to Disease in 15% of Patients
08/05/2024
Approximately 15% of patients with Parkinson disease (PD) in a large international cohort had potentially actionable genetic variants, according to a study published in the journal Brain.
Approximately 15% of patients with Parkinson disease (PD) in a large international cohort had potentially actionable genetic variants, according to a study published in the journal Brain.
Approximately 15% of patients...
08/05/2024
Annals of Long-Term Care
News
MRI-Guided Focused Ultrasound Subthalamotomy for Treating Parkinson Disease
07/23/2024
A study assessed the safety and effectiveness of staged bilateral MRI-guided focused ultrasound subthalamotomy (FUS-STN) to treat Parkinson Disease (PD).
A study assessed the safety and effectiveness of staged bilateral MRI-guided focused ultrasound subthalamotomy (FUS-STN) to treat Parkinson Disease (PD).
A study assessed the safety and...
07/23/2024
Annals of Long-Term Care
News
Researchers Use AI to Predict Parkinson Disease Up to 7 Years
06/20/2024
Researchers developed a blood test using artificial intelligence (AI) to predict Parkinson disease up to 7 years.
Researchers developed a blood test using artificial intelligence (AI) to predict Parkinson disease up to 7 years.
Researchers developed a blood...
06/20/2024
Annals of Long-Term Care

Advertisement

News
Investigational PD Cell Therapy Receives FDA RMAT Designation
06/06/2024
Jolynn Tumolo
The US Food and Drug Administration (FDA) granted the investigational cell therapy bemdaneprocel a Regenerative Medicine Advanced Therapy (RMAT) designation for the treatment of Parkinson disease (PD), announced bemdaneprocel developer...
The US Food and Drug Administration (FDA) granted the investigational cell therapy bemdaneprocel a Regenerative Medicine Advanced Therapy (RMAT) designation for the treatment of Parkinson disease (PD), announced bemdaneprocel developer...
The US Food and Drug...
06/06/2024
Annals of Long-Term Care
News
Exposure to Airborne Manganese, Beryllium, and Nickel May Increase the Risk of Parkinson Disease
05/21/2024
Lisa Kuhns, PhD
Environmental exposure to airborne manganese, beryllium, and nickel may increase the risk of Parkinson disease (PD), according to study results presented at the 2024 Annual Meeting of the American Academy of Neurology.
Environmental exposure to airborne manganese, beryllium, and nickel may increase the risk of Parkinson disease (PD), according to study results presented at the 2024 Annual Meeting of the American Academy of Neurology.
Environmental exposure to...
05/21/2024
Annals of Long-Term Care
News
Neurostimulation Produces a Stable Quality of Life Up to 5 Years in Patients With Parkinson Disease, Study Finds
05/08/2024
Lisa Kuhns, PhD
Deep brain stimulation of the subthalamic nucleus (STN-DBS) results in a stable quality of life (QOL) over 5 years in patients with advanced Parkinson disease, according to a study published in JAMA Network Open.
Deep brain stimulation of the subthalamic nucleus (STN-DBS) results in a stable quality of life (QOL) over 5 years in patients with advanced Parkinson disease, according to a study published in JAMA Network Open.
Deep brain stimulation of the...
05/08/2024
Annals of Long-Term Care

Advertisement

News
Improving Patient Engagement in Value-Based Care
04/09/2024

Emry Lloyd

Emry Lloyd
Apathy can affect how patients engage in health care and receive care. Physicians and providers need to discover new and engaging ways to get patients more involved in value-based care.
Apathy can affect how patients engage in health care and receive care. Physicians and providers need to discover new and engaging ways to get patients more involved in value-based care.
Apathy can affect how patients...
04/09/2024
Annals of Long-Term Care
News
Skin Biopsies Show Promise as Diagnostic Tool for Synucleinopathies Such as Parkinson Disease
04/04/2024
Hannah Musick
Skin biopsies may hold promise as a diagnostic tool for synucleinopathies like Parkinson disease, with high rates of phosphorylated α-synuclein detected in affected individuals compared to controls.
Skin biopsies may hold promise as a diagnostic tool for synucleinopathies like Parkinson disease, with high rates of phosphorylated α-synuclein detected in affected individuals compared to controls.
Skin biopsies may hold promise...
04/04/2024
Annals of Long-Term Care
News
Guidance Aims to Protect PD Patients from Harm During Hospitalization
03/19/2024
Jolynn Tumolo
Recommendations to improve the hospitalization experience of patients with Parkinson disease (PD), released last year by the Parkinson’s Foundation, aim to ease the increased risk of preventable harm for the hundreds of thousands of people...
Recommendations to improve the hospitalization experience of patients with Parkinson disease (PD), released last year by the Parkinson’s Foundation, aim to ease the increased risk of preventable harm for the hundreds of thousands of people...
Recommendations to improve the...
03/19/2024
Annals of Long-Term Care

Advertisement

News
Utilizing Gold Nanoparticles in Therapy for Patients With Parkinson Disease
03/05/2024

Emry Lloyd

Emry Lloyd
Researchers discover various uses of green synthesis for patients with Parkinson disease and the benefits of this nanoparticle synthesis with gold.
Researchers discover various uses of green synthesis for patients with Parkinson disease and the benefits of this nanoparticle synthesis with gold.
Researchers discover various...
03/05/2024
Annals of Long-Term Care

Advertisement

Advertisement

Annals of Long-Term Care Newsletter

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use